Eyenovia, Inc.

NASDAQ:EYEN

0.09 (USD) • At close January 14, 2025
Bedrijfsnaam Eyenovia, Inc.
Symbool EYEN
Munteenheid USD
Prijs 0.086
Beurswaarde 9,582,550
Dividendpercentage 0%
52-weken bereik 0.077 - 2.57
Industrie Biotechnology
Sector Healthcare
CEO Mr. Michael M. Rowe
Website https://www.eyenovia.com

An error occurred while fetching data.

Over Eyenovia, Inc.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for

Vergelijkbare Aandelen

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.15 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.17 USD

Journey Medical Corporation logo

Journey Medical Corporation

DERM

3.73 USD

BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

BCTX

0.39 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

0.342 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)